Guide price only. Final cost is confirmed after assessment.
Cingal is a groundbreaking treatment offered at the London Cartilage Clinic for those suffering from osteoarthritis. It uniquely combines a corticosteroid with high-concentration hyaluronic acid in a single injection, providing both immediate and long-lasting relief from joint pain.
Reviewed byProfessor Paul Lee MBBch, FRCS (Tr & Orth), PhDCartilage and joint preservation expertise
Cingal combines high-concentration hyaluronic acid with corticosteroid in one injection, delivering both lubrication support and anti-inflammatory action.
This dual-action profile can be beneficial for patients needing both immediate comfort and medium-term joint support.
Cingal is delivered as an outpatient treatment with minimal interruption to daily routine and no requirement for major surgery.
At London Cartilage Clinic, Cingal is integrated into a broader osteoarthritis care pathway to maximise functional gains, not just short-term pain relief.
Cingal is effective in treating various symptoms of osteoarthritis, including pain, swelling, stiffness, loss of physical function, and limited motion in the joint.
The relief from a Cingal injection is proven to last for 6 months, offering long-term alleviation from osteoarthritis symptoms.
Cingal is ideal for individuals with osteoarthritis, particularly those looking for non-surgical treatment options. A consultation with our specialists will help determine if Cingal is the right choice for you.
Cingal contains a mixture of a corticosteroid and naturally occurring hyaluronan. This is designed to bolster the lubrication of the knee joint and its ability to absorb impacts. Which, coupled with the reduction in inflammation, can be effective at providing long-term relief from knee pain.
Although Cingal is considered to be among the most well tolerated treatments, no medication can be completely risk free. Cingal injections can cause swelling, aching, bruising, redness, or a rash to develop around the site. You may also experience skin thinning. These reactions are typically mild in nature. Nevertheless, if you have any concerns don’t hesitate to speak to your healthcare professional.
Still have more specific concerns?
Free Discovery CallLondon Cartilage Clinic
Clinical updates, cartilage treatment guidance, and recovery-focused articles from our specialist team.
ChondroFiller injection suits adults with full-thickness articular cartilage damage, recruiting host cells through an injectable collagen scaffold to deliver 70–85% meaningful symptom relief by five years and 3–8% reoperation rates.
Microfracture creates fibrocartilage deficient in glycosaminoglycans, the molecules that absorb joint compression; this tissue progressively fails from year two. ChondroFiller injection uses a collagen scaffold to avoid bone damage and sustain organised repair through years two to five.
Most meniscus tears, particularly degenerative ones in adults over 35, respond to physiotherapy as well as surgery. Randomised trials show conservative management preserves the surgical option if needed, with equivalent long-term outcomes.
